GlassScriptPhysician profile
Daniel G Maico
NPI 1740205491
$285.23
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $215 · 2021: $54.42 · 2022: $16.12.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $70.54 | 2021-2022 | |
| Shire North American Group INC | $39.21 | 2019 | |
| Shionogi INC | $33.57 | 2019 | |
| Pfizer INC. | $31.53 | 2019 | |
| Abbvie INC. | $29.88 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.02 | 2019 | |
| Boston Scientific Corporation | $23.00 | 2019 | |
| Allergan, INC. | $19.55 | 2019 | |
| Merck Sharp & Dohme LLC | $13.93 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Maico listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.